Bold ideas and thinking outside the box to treat Alzheimer’s disease

M3 Biotechnology is advancing a novel, potentially transformative approach for the treatment of Alzheimer’s disease and other neurodegenerative diseases. Unlike other products approved and in development, M3’s drug candidates hold the potential to reverse or halt the degenerative process.

Nov 07, 2018
0
0
Page of

Athira Pharma, Inc.

Athira Pharma, Inc. is a drug development company striving to improve human health by advancing new therapies for neurodegenerative diseases like Alzheimer’s and Parkinson’s.Our approach is “first-in-class” with the potential to halt or even reverse degeneration of the nervous system. We are committed to advancing novel and innovative research, developing products that are affordable and accessible in alignment with our strategy focused on the people that we ultimately aim to serve with our therapies. We are mission-driven to restore lives by advancing bold therapies, thoughtfully and urgently.

No comments yet.